ScienceDaily
•79% Informative
It mainly causes common cold symptoms in healthy adults but can cause more serious lung infections in infants, the immunocompromised and older individuals.
The U.S RSV ood and Drug Administration approved GSK's Arexvy vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older. Emory University MD Guido Silves RSV UNC JCI Insight aryFeed_h Angela Wahl t_ PhD lG Raymond Pickles an PhD J. Victor Garcia ed PhD ghLight the International Center for the Advancement of Translational Science (ICATS n K the Department of Microbiology and Immunology ighLig the Institute for Global Health and Infectious Diseases Li IGHID xt__N the UNC School of Medicine pan> RSV Vaccine ightText__NxlGi" RSV o Moderna RSV tText__NxlGi">Pfizer 60 years of age and older RSV yFeed_highLightTex Wahl xlGi">RSV the UNC ICATS span> GSK RSV pan> RSV U.S. Food and Drug Administration RSV summaryFeed_highLightText__NxlGi">May 3 RSV RSV the UNC Microbiology and Immunology Departmenttwo RSV Gi">Raymond Pickles RSV UNC ICATS J. V RSV or Garcia RSV NxlGi">RSV RSV < RSV n class="summaryFeed_highLightText__NxlGi">RSV
VR Score
89
Informative language
97
Neutral language
41
Article tone
formal
Language
English
Language complexity
80
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links